{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:54:30Z","timestamp":1766555670800,"version":"3.48.0"},"reference-count":13,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2024,10,14]]},"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1136\/ejhpharm-2024-004334","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T07:50:28Z","timestamp":1729929028000},"page":"19-21","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Ceftaroline combination therapy for methicillin resistant coagulase negative\n                    <i>Staphylococcus<\/i>\n                    bacteraemia and endocarditis"],"prefix":"10.1136","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-1451","authenticated-orcid":false,"given":"Sunish","family":"Shah","sequence":"first","affiliation":[{"name":"Antimicrobial Management Program, University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simi","family":"Padival","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,10,26]]},"reference":[{"key":"2025122321350573000_33.1.19.1","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02483-18","article-title":"Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia","volume":"63","author":"Geriak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2025122321350573000_33.1.19.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.05.061"},{"key":"2025122321350573000_33.1.19.3","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.8486","article-title":"Daptomycin plus ceftaroline salvage therapy for persistent Staphylococcus epidermidis bacteremia","volume":"12","author":"Zhang","year":"2024","journal-title":"Clin Case Rep"},{"key":"2025122321350573000_33.1.19.4","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2019-002183"},{"key":"2025122321350573000_33.1.19.5","article-title":"Daptomycin and Ceftaroline Combination Therapy in Complicated Endovascular Infections Caused by Methicillin-Resistant Staphylococcus epidermidis","volume":"16","author":"Policarpo","year":"2024","journal-title":"Cureus"},{"key":"2025122321350573000_33.1.19.6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10096-024-04783-1","article-title":"Recurrent bacteremia and endocarditis due to Staphylococcus capitis in a patient with Bowen\u2019s disease: a case report","volume":"43","author":"D\u00edez-Vidal","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025122321350573000_33.1.19.7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01525-12"},{"key":"2025122321350573000_33.1.19.8","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz538","article-title":"Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025122321350573000_33.1.19.9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jiac.2018.03.003","article-title":"Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis","volume":"24","author":"Ramos-Mart\u00ednez","year":"2018","journal-title":"J Infect Chemother"},{"key":"2025122321350573000_33.1.19.10","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1093\/cid\/ciaa1040","article-title":"Is Rifampin Use Associated With Better Outcome in Staphylococcal Prosthetic Valve Endocarditis? A Multicenter Retrospective Study","volume":"72","author":"Le Bot","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025122321350573000_33.1.19.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000296"},{"key":"2025122321350573000_33.1.19.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304103","article-title":"Short versus long duration of ceftaroline combination therapy and outcomes in persistent or high-grade MRSA bacteremia: A retrospective single-center study","volume":"19","author":"Cabanilla","year":"2024","journal-title":"PLoS One"},{"key":"2025122321350573000_33.1.19.13","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab327","article-title":"Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline","volume":"8","author":"Nichols","year":"2021","journal-title":"Open Forum Infect Dis"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2024-004334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:35:27Z","timestamp":1766554527000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2024-004334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,23]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/ejhpharm-2024-004334"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2024-004334","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2024,10,26]]}}}